Soft Tissue and Bone Sarcoma
Soft tissue and bone sarcomas disproportionately affect children, adolescents, and young adults. Although considered a rare disease, sarcomas continue to have a devastating effect on these patients and their loved ones, and their impact on our society far exceed their relatively low prevalence. Beca...
Uloženo v:
| Médium: | Online |
|---|---|
| Jazyk: | angličtina |
| Vydáno: |
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Témata: | |
| On-line přístup: | 16621 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| _version_ | 1869519885066829824 |
|---|---|
| collection | Directory of Open Access Books |
| description | Soft tissue and bone sarcomas disproportionately affect children, adolescents, and young adults. Although considered a rare disease, sarcomas continue to have a devastating effect on these patients and their loved ones, and their impact on our society far exceed their relatively low prevalence. Because of its rarity and heterogeneity, clinical decision making on management of sarcomas are often individualized and without a consensus treatment strategy. Furthermore, research to improve clinical outcomes are particularly challenging as sizeable studies are hard to produce. By improving our knowledge about the molecular biology of sarcomas, we hope to identify new treatment strategies and targets for further drug development. [...] |
| format | Online |
| id | doab-20.500.12854ir-59643 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-596432022-01-31T13:16:51Z Soft Tissue and Bone Sarcoma sarcoma bone tumor drug development connective tissue oncology biomarker osteosarcoma Soft tissue and bone sarcomas disproportionately affect children, adolescents, and young adults. Although considered a rare disease, sarcomas continue to have a devastating effect on these patients and their loved ones, and their impact on our society far exceed their relatively low prevalence. Because of its rarity and heterogeneity, clinical decision making on management of sarcomas are often individualized and without a consensus treatment strategy. Furthermore, research to improve clinical outcomes are particularly challenging as sizeable studies are hard to produce. By improving our knowledge about the molecular biology of sarcomas, we hope to identify new treatment strategies and targets for further drug development. [...] 2021-02-12T04:00:28Z 2021-02-12T04:00:28Z 2015-01-12 11:17:42 2014 book 16621 9783906980461 9783906980584 https://directory.doabooks.org/handle/20.500.12854/59643 eng application/octet-stream Attribution 4.0 International http://www.amazon.com/dp/3906980464 https://www.mdpi.com/books/pdfview/book/65 MDPI - Multidisciplinary Digital Publishing Institute 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783906980461 9783906980584 156 open access |
| spellingShingle | sarcoma bone tumor drug development connective tissue oncology biomarker osteosarcoma Soft Tissue and Bone Sarcoma |
| title | Soft Tissue and Bone Sarcoma |
| title_full | Soft Tissue and Bone Sarcoma |
| title_fullStr | Soft Tissue and Bone Sarcoma |
| title_full_unstemmed | Soft Tissue and Bone Sarcoma |
| title_short | Soft Tissue and Bone Sarcoma |
| title_sort | soft tissue and bone sarcoma |
| topic | sarcoma bone tumor drug development connective tissue oncology biomarker osteosarcoma |
| topic_facet | sarcoma bone tumor drug development connective tissue oncology biomarker osteosarcoma |
| url | 16621 |